Related Experiment Video
Updated: Apr 19, 2026

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
Published on: February 28, 2025
[Cannabinoid hyperemesis syndrome: about 6 cases].
J Bertolino1, L Abdo2, D Khau3
1Service de médecine interne, hôpital Nord, Assistance publique-Hôpitaux de Marseille (AP-HM), chemin des Bourrely, 13915 Marseille cedex 15, France; Université d'Aix-Marseille , 13284 Marseille, France.
Cannabinoid hyperemesis syndrome (CHS), marked by cyclic nausea and vomiting relieved by hot showers, affects young adults using cannabis long-term. Definitive cannabis cessation is the primary treatment for symptom resolution.
Area of Science:
- Gastroenterology
- Toxicology
- Addiction Medicine
Background:
- Cannabinoid hyperemesis syndrome (CHS) is a condition causing cyclical nausea, vomiting, and abdominal pain in chronic, long-term cannabis users.
- A hallmark of CHS is the paradoxical relief of symptoms through hot showers.
Observation:
- Six cases of CHS are presented, involving three men and three women, all chronic cannabis consumers.
- Patients experienced nausea, vomiting, abdominal pain (worse in the morning), and weight loss, with symptom improvement after hot showers.
- Standard medical investigations were inconclusive, delaying diagnosis.
Findings:
- CHS diagnosis is primarily clinical, based on characteristic symptoms and response to hot bathing.
- Undiagnosed CHS leads to extensive, costly, and potentially invasive medical evaluations.
- The underlying pathophysiology of CHS remains unclear.
Implications:
- Early clinical recognition of CHS is crucial to prevent unnecessary medical interventions.
- Definitive cessation of cannabis use is the cornerstone of effective CHS management.
- Further research into CHS pathophysiology is needed to guide targeted therapeutic strategies.
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Hyperosmolar Hyperglycemic State
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Pathophysiology of Vomiting
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

